Moa Technology Limited

Active10895764 Private limited company

Incorporated: 2 August 2017 (9 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: Alexandre Biau
Virginia Corless
Agri Investment Fund BV
all 8 directors
Owned by: Oxford Science Enterprises Holdings Limited
Parkwalk Advisors Ltd
Accounts type: Full
Region: South East
Address: The Bellhouse Building The Magdalen Centre
The Oxford Science Park
1 Robert Robinson Avenue
Oxford
OX4 4GA

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 15 August 2027
Last conf. stmt: 1 August 2026

Charges

Total: 1
Outstanding: 0
Part satisfied: 0
Satisfied: 1

Officers 9 active

Officer details are public data from the Companies House register.

Biau, Alexandre

Director · Appointed 14 July 2026

French

Born January 1985 (41)

Corless, Virginia, Dr

Director · Appointed 14 July 2026

American

Born November 1982

Agri Investment Fund Bv

Corporate Director · Appointed 14 July 2026

Yoder, Amy

Director · Appointed 1 April 2024

American

Born March 1967 (59)

Van Lengerich, Hartmut

Director · Appointed 1 January 2024

German

Born October 1960 (66)

Pennsec Limited

Corporate Secretary · Appointed 31 January 2020

Also at Cottonconnect Trustees Limited, Nexus4climate Ltd (proposed for strike-off), Penntrust Limited · more companies

Parkwalk Advisors Ltd

Corporate Director · Appointed 16 May 2019

Also at Phoremost Limited, Ikarovec Limited, Brainomix Limited · more companies

Lawrence, David Kenneth, Dr

Director · Appointed 16 January 2019

Also at John Innes Foundation, John Innes Bioprospects Limited, Masts Management Company Limited · more companies

British

Born March 1949 (77)

Fiennes, Martin Guy

Director · Appointed 25 October 2017

Also at M.D. Hamilton (Farms) Limited, The H D H Wills 1965 Charitable Trust, Wild Bioscience Ltd · more companies

British

Born February 1961 (65)

Officer history (6 former)

14 July 2026

Appointed Corless, Virginia, Dr as Director

14 July 2026

Appointed Agri Investment Fund Bv as Corporate Director

14 July 2026

Appointed Biau, Alexandre as Director

14 July 2026

Resigned Dolan, Liam, Professor as Director

1 April 2024

Appointed Yoder, Amy as Director

1 January 2024

Appointed Van Lengerich, Hartmut as Director

1 January 2024

Resigned Parry, Hadyn St Pierre as Director

11 May 2022

Resigned Workman, Adam Craig as Director

17 February 2020

Resigned Kemp, Charles Frederick, Dr as Director

17 February 2020

Appointed Workman, Adam Craig as Director

31 January 2020

Appointed Pennsec Limited as Corporate Secretary

31 January 2020

Resigned Ip2ipo Services Limited as Corporate Secretary

16 May 2019

Resigned Ip2ipo Services Limited as Corporate Director

16 May 2019

Appointed Parkwalk Advisors Ltd as Corporate Director

1 February 2019

Appointed Parry, Hadyn St Pierre as Director

16 January 2019

Appointed Lawrence, David Kenneth, Dr as Director

11 December 2017

Appointed Ip2ipo Services Limited as Corporate Secretary

25 October 2017

Appointed Fiennes, Martin Guy as Director

25 October 2017

Appointed Ip2ipo Services Limited as Corporate Director

25 October 2017

Appointed Kemp, Charles Frederick, Dr as Director

2 August 2017

Appointed Dolan, Liam, Professor as Director

Ownership 2 active

People and entities with significant control, from the Companies House PSC register

Oxford Science Enterprises Holdings Limited

Corporate entity · Notified 31 March 2025

Owns 25–50% of shares

Holds 25–50% of voting rights

Corporate

Reg. no. 13564426

Parkwalk Advisors Ltd

Corporate entity · Notified 4 July 2019

Owns 25–50% of shares

Holds 25–50% of voting rights

Limited Company

Reg. no. 06925696

Former controllers (2)

31 March 2025

Ceased Oxford Science Enterprises PLC — Owns 25–50% of shares

27 October 2017

Ceased Liam Dolan — Owns 25–50% of shares

Group structure 58 shown

Ownership group derived from the Companies House PSC register

IP Group PLC

Fusion IP Cardiff Limited Owns 75–100% of shares

Demasq Limited DissolvedOwns 25–50% of shares

Fusion IP Sheffield Limited Owns 75–100% of shares

Ip2ipo Carry Partner Limited Owns 75–100% of shares

Ip2ipo Investments Limited Owns 75–100% of shares

Ip2ipo Limited Owns 75–100% of shares

Alesi Surgical Limited Owns 25–50% of shares

Boxarr Limited Owns 25–50% of shares

Emdot Limited In liquidationOwns 25–50% of shares

IP Venture Fund (FP) Limited Partnership Part right to 25–50% of surplus assets

Ip2ipo Americas Limited Owns 75–100% of shares

Ip2ipo Anz Carry Limited Owns 75–100% of shares

Ipg Usa (LP) Limited Owns 75–100% of shares

Istesso Limited Owns 25–50% of shares

Istesso 2 Limited Owns 75–100% of shares

Istesso 3 Limited Owns 75–100% of shares

Istesso Therapeutics Limited Owns 75–100% of shares

MBS5 Limited Owns 75–100% of shares

PH Therapeutics Limited Owns 50–75% of shares

Ip2ipo Nominees Limited Owns 75–100% of shares

Bramble Energy Limited In administrationOwns 25–50% of shares

Ip2ipo Services Limited Owns 75–100% of shares

Magnomatics Limited Owns 25–50% of shares

Parkwalk Advisors Ltd Owns 75–100% of shares

Cambridge Touch Technologies Ltd In liquidationHolds 25–50% of voting rights

Crypto Quantique Limited In liquidationOwns 25–50% of shares

Ikarovec Limited Owns 25–50% of shares

Lettus Grow Ltd Owns 25–50% of shares

Mind Foundry Limited Holds 25–50% of voting rights

Moa Technology Limited This company Owns 25–50% of shares

Opsydia Limited Has significant influence or control

Oxford Endovascular Limited Holds 25–50% of voting rights

Pervasid Limited Owns 25–50% of shares

Predictimmune Limited Status not confirmedOwns 25–50% of shares

Psyomics Ltd Owns 50–75% of shares

Salunda Limited Holds 25–50% of voting rights

Symetrica Limited Has significant influence or control

Symetrica Security Ltd Owns 75–100% of shares

Top Technology Ventures Limited Owns 75–100% of shares

IP Capital Limited Owns 75–100% of shares

IP Venture Fund II (GP) LLP Right to 75–100% of surplus assets

IP Ventures (Scotland) Limited Owns 75–100% of shares

Ip2ipo Portfolio (GP) Limited Owns 75–100% of shares

Accelercomm Ltd Owns 25–50% of shares

Audioscenic Limited Owns 25–50% of shares

Barocal Ltd Owns 25–50% of shares

First Light Fusion Limited Owns 25–50% of shares

Ibex Innovations Ltd Has significant influence or control

Intrinsic Semiconductor Technologies Limited Owns 25–50% of shares

Ionix Advanced Technologies Ltd Owns 25–50% of shares

Kiko Ventures Limited Owns 75–100% of shares

Lumai Limited Owns 25–50% of shares

Mixergy Limited Has significant influence or control

Oxehealth Limited Owns 25–50% of shares

Touchstone Innovations Limited Owns 75–100% of shares

Ip2ipo Innovations Limited Owns 75–100% of shares

Touchstone Innovations Businesses LLP Right to 75–100% of surplus assets

Financials

Balance sheet as at 31 December 2025 · full accounts

Net Assets: £3,210,075
Cash: £5,749,406
Turnover: £2,518,796
Profit Before Tax: (£11,168,691)
Employees: 83

Debt Ratio: 63%
Current Ratio: 1.5x
Profit Margin: -443%
Return on Equity: -294%

Trend

Turnover

Balance sheet detail

	2025	2024	2021	2019
Fixed Assets	£732,093	£1,171,329	£652,676	£536,778
Current Assets	£7,905,567	£13,834,046	£4,900,425	£5,700,653
Debtors	£2,156,161	£2,409,357
Cash	£5,749,406	£11,424,689	£3,553,255	£5,569,103
Creditors (< 1 year)	£5,427,585	£2,846,978	£618,531	£163,635
Net Current Assets	£2,477,982	£10,987,068	£4,281,894	£5,537,018
Net Assets	£3,210,075	£12,158,397	£4,934,570	£6,073,796
Shareholder Funds	£3,210,075	£12,158,397	£4,934,570	£6,073,796

Turnover	£2,518,796	£1,900,244
Cost of Sales	£69,399	£22,000
Gross Profit	£2,449,397	£1,878,244
Admin Expenses	£11,785,003	£12,922,143
Staff Costs	£6,193,332	£5,832,182
Operating Profit	(£11,419,422)	(£13,353,083)
Profit Before Tax	(£11,168,691)	(£12,671,504)
Tax	(£1,744,809)	(£1,901,826)
Profit for Period	(£9,423,882)	(£10,769,678)	(£4,251,048)	(£1,222,418)

Filings 83

Date	Description	Made Up To
13 August 2026	Confirmation statement with updates	1 August 2026
12 August 2026	Replacement filing for the appointment of a director
16 July 2026	Appointment of a director
16 July 2026	Appointment of a director
15 July 2026	Statement of capital following an allotment of shares